[1] JOY T R， HEGELE R A. Narrative review： statin-related myopathy [J]. Ann Intern Med， 2009，150(12：858-868. [2] BRUCKERT E， HAYEM G， DEJAGER S， et al. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - The PRIMO Study [J]. Cardiovasc Drugs Ther， 2005，19(6：403-414. [3] MOLOKHIAL M， MCKEIGUE P， CURCIN V， et al. Statin induced myopathy and myalgia： Time trend analysis and comparison of risk associated with statin class from 1991-2006 [J]. PLoS One， 2008 ，3(6：2522. [4] GOUNDEN R， BLOCKMAN M. Statin-induced myopathy [J]. Cardiovasc J Afr， 2008，19(3：156-157. [5] MRC/BHF HEART PROTECTION STUDY COLLABORATIVE GROUP， ARMITAGE J， BOWMAN L， et al. Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo- controlled trial in 20，536 high-risk people [J]. BMC Clin Pharmacol， 2009， 9：6. [6] KAPUR N K， MUSUNURU K. Clinical efficiency and safety of statins in managing cardiovascular risk [J]. Vasc Health Risk Manag，2008，4(2 ：341-353. [7] OWCZAREK J， JASN′SKA M， ORSZULAK-MICHALAK D. Drug-induced myopathies. An overview of the possible mechanisms [J]. Pharmacol Rep，2005，57(1：23-34. [8] SILVA M， MATTHEWS M L， JARVIS C， et al. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy [J]. Clin Ther， 2007，29(2：253-260. [9] JOSAN K， MCALISTER F A. Cholesterol lowering for secondary prevention what statin dose should we use [J]. Vasc Health Risk Manag，2007， 3(5：615-627. [10] JACOBSON T A. Toward "Pain-Free" statin prescribing： clinical algorithm for diagnosis and management of myalgia [J]. Mayo Clin Proc， 2008，83(6：687-700. [11] ESCOBAR C， ECHARRI R， BARRIOS V. Relative safety profiles of high dose statin regimens [J]. Vasc Health Risk Manag，2008，4(3：525-533. [12] SEWRIGHT K A， CLARKSON P M， THOMPSON P D. Statin myopathy： incidence， risk factors， and pathophysiology [J]. Curr Ateheroscler Rep， 2007，9(5：389-396. [13] YU J G， SEWRIGHT K， HUBAL M J， et al. Investigation of gene expression in C2C12 myotubes following simvastatin application and mechanical strain [J]. J Atheroscler Thromb， 2009，16(1：21-29. [14] HANAI J， CAO P， TANKSALE P， et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity [J]. J Clin Invest， 2007，117 (12 ：3940-3951. [15] LINK E， PARISH S， ARMITAGE J， et al. SLCO1B1 Variants and statin-induced myopathy- a genomewide study [J]. N Engl J Med， 2008，359(8：789-799. [16] OH J， BAN M R， MISKIE B A， et al. Genetic determinants of statin intolerance [J]. Lipids Health Dis， 2007，6：7. [17] VLADUTIU G D. Genetic predisposition to statin myopathy [J]. Curr Opin Rheumatol， 2008 ，20(6：648-655. [18] FRANK RE J R. Statin induced myopathy [J]. J Insur Med， 2009，41(2：132-135. [19] ROBINSON J G. Manangement of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin [J]. Vasc Health Risk Manag，2009，5(1：31-43. [20] TAYLOR A J， VILLINES T C， STANEK E J， et al. Extended-release niacin or ezetimibe and carotid intima-media thickness [J]. N Engl J Med， 2009，361(22：2113-2122. [21] BACKES J M， GIBSON C A， HOWARD P A. Optimal lipid modification： the rationale for combination therapy [J]. Vasc Health Risk Manag，2005，1(4：317-331. [22] BAYS H. Saftey of niacin and simvastatin combined therapy [J]. Am J Cardiol， 2008，101(8A：3-8. [23] GAZI I F， DASKALOPOUOU S S， NAIR D R， et al. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin [J]. Curr Med Res Opin， 2007，23(9：2183-2192. [24] MARCOFF L， THOMPSON P D. The role of coenzyme Q10 in statin-associated myopathy： a systematic review [J]. J Am Coll Cardiol， 2007，49(23：2231-2237. [25] HARPER C R， JACOBSON T A. The broad spectrum of statin myopathy： from myalgia to rhabdomyolysis [J]. Curr Opin Lipidol， 2007，18(4：401-408. [26] GINTER E， SIMKO V. Statins： the drugs for the 21st century? [J]. Bratisl Lek Listy， 2009，110(10：664-668. [27] KLOPSTOCK T. Drug-induced myopathies [J]. Curr Opin Neurol， 2008，21(5：590-595.
PDF(424 KB)
